Skip to main content
Cell Bio Human Tech Co., Ltd logo

Cell Bio Human Tech Co., Ltd — Investor Relations & Filings

Ticker · 318160 ISIN · KR7318160009 KO Professional, scientific and technical activities
Open in API
Filings indexed 146 across all filing types
Latest filing 2023-09-01 Major Shareholding Noti…
Country KR South Korea
Listing KO 318160

About Cell Bio Human Tech Co., Ltd

http://cellbiohumantech.co.kr/en/

Cell Bio Human Tech Co., Ltd. is a company that develops and manufactures advanced nonwoven fabrics for the cosmetics sector. Utilizing cellulose reaction technology, the company produces specialized materials primarily for sheet masks and skincare pads. Its products, derived from various cellulose fibers, are engineered for differentiated performance, offering features such as high transparency and adhesion. The company provides customizable and eco-friendly fabric solutions, with key product lines including PT Cell and S Cell.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, volumes, and the purpose of holding (management influence). This type of filing is a standard regulatory requirement for significant ownership changes, which falls under the 'Major Shareholding Notification' category.
2023-09-01 Korean
[기재정정]반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Cell Bio Human Tech'. It contains detailed financial information, management discussion, and corporate governance details for the period of 2023-01-01 to 2023-06-30. In the context of Korean financial filings (DART), a '반기보고서' is the standard comprehensive interim financial report. According to the provided definitions, this falls under the 'Interim / Quarterly Report' (IR) category. H1 2023
2023-08-16 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Cell Bio Human Tech' covering the period from January 1, 2023, to June 30, 2023. It contains detailed corporate information, business descriptions, and financial data structures typical of a formal interim report filed with the Financial Supervisory Service (FSS) in South Korea. According to the provided definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-11 Korean
생산중단
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding the suspension of production at a specific facility (Ansan headquarters) by Cell Bio Human Tech. It details the reasons for the suspension (relocation of production equipment to a Vietnamese subsidiary), the financial impact, and future plans. This type of disclosure is a standard regulatory filing required by stock exchanges to inform investors of material operational changes. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-07-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the resignation of an outside director (Jung Sung-hoon) from the company CellBioHumanTech. This falls under the category of changes in the company's board of directors or senior management.
2023-06-21 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Results of Disposal of Treasury Shares' (자기주식처분결과보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific quantity, date, and method of treasury shares disposed of by the company. This falls under the category of a company reporting its own share transactions, specifically the disposal of treasury shares, which aligns with the 'Transaction in Own Shares' (POS) category.
2023-06-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.